Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
Recruiting · NCT06934642 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effect of Tirzepatide on Markers of MASLD in Patients With Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition | Recruiting | Early phase 1 | 2026-09-04 | NCT06934642 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| American Cancer Society, Inc. | 60 |
| University of New Mexico | 69 |
| University of New Mexico Cancer Center | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of New Mexico Health Sciences Center | Albuquerque | United States | 12 |